Literature DB >> 4064549

A retrospective study of the role of radiotherapy in the treatment of soft-tissue sarcoma.

J A Dewar, W Duncan.   

Abstract

One hundred and forty patients with soft-tissue sarcoma were seen between 1965 and 1974 and the pathology has been reviewed in 93 cases. One hundred and eight patients were treated radically. Their overall survival rate was 53% at 5 years and 41% at 10 years. Overall local control was 63% but primary local control varied considerably with treatment, being highest for those receiving surgery and post-operative radiotherapy. The poor prognosis of patients with paravertebral tumours is confirmed.

Entities:  

Mesh：

Year:  1985        PMID： 4064549     DOI： 10.1016/s0009-9260(85)80252-x

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  5 in total

Review 1.  [Bone and soft tissue tumors--general strategy of therapy].

Authors:  H P Bruch
Journal:  Langenbecks Arch Chir       Date:  1987

2.  Treatment results of fast neutron irradiation in soft tissue sarcomas.

Authors:  F J Prott; O Micke; U Haverkamp; R Pötter; N Willich
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

Review 3.  [Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Authors:  Hildegard Pape; Klaus Orth; Rainer Engers; Christiane Matuschek; Anja Müller; Karl-Axel Hartmann; Peter Arne Gerber; Guido Lammering; Daniel Habermehl; Roland Fenk; Wilfried Budach; Stephan Gripp; Matthias Peiper; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  Prognostic factors for survival in soft tissue sarcoma.

Authors:  J N el-Jabbour; S S Akhtar; G R Kerr; K M McLaren; J F Smyth; A Rodger; R C Leonard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

5.  Spindle Cell Sarcoma of the Paraspinal Musculature with Late Pulmonary Metastases.

Authors:  Austin H Allen; Ashley C Gullixson
Journal:  Am J Case Rep       Date:  2019-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.